Study day | −42 | −35 | −21 | 0 | 3 | 7 | 10 | 14 | 21 | 28 |
Group V | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 |
IDEXX | 0 | 0 | 9 | 10 | 9 | 10 | 10 | 10 | 9 | 9 |
INgezim | 0 | 0 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
HIPRA A/S | 0 | 0 | 1 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
HIPRA E/S | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 3 | 1 | 3 |
QIAGEN | 0 | 0 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
AJ | 0 | 0 | 8 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Group N | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 | n = 10 |
IDEXX | n.d. | n.d. | n.d. | 0 | 0 | 0 | 6 | 10 | 10 | 10 |
INgezim | n.d. | n.d. | n.d. | 0 | 0 | 0 | 10 | 10 | 10 | 10 |
HIPRA A/S | n.d. | n.d. | n.d. | 0 | 0 | 0 | 0 | 0 | 8 | 10 |
HIPRA E/S | n.d. | n.d. | n.d. | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
QIAGEN | n.d. | n.d. | n.d. | 0 | 0 | 0 | 7 | 10 | 10 | 10 |
AJ | n.d. | n.d. | n.d. | 0 | 0 | 0 | 0 | 8 | 10 | 10 |